Versant Capital Management Inc Increases Holdings in DaVita Inc. (NYSE:DVA)

Versant Capital Management Inc increased its position in shares of DaVita Inc. (NYSE:DVA) by 58.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 457 shares of the company’s stock after purchasing an additional 169 shares during the quarter. Versant Capital Management Inc’s holdings in DaVita were worth $68,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the company. Transcendent Capital Group LLC acquired a new position in shares of DaVita during the 3rd quarter worth $25,000. Blue Trust Inc. raised its position in DaVita by 56.4% during the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after acquiring an additional 119 shares during the last quarter. Quarry LP purchased a new stake in shares of DaVita in the third quarter valued at about $60,000. Point72 Hong Kong Ltd acquired a new stake in shares of DaVita in the second quarter valued at approximately $68,000. Finally, Strategic Financial Concepts LLC purchased a new position in shares of DaVita during the 2nd quarter worth approximately $79,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Truist Financial upped their target price on DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Barclays boosted their target price on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $161.80.

DaVita Price Performance

DVA stock opened at $152.82 on Monday. The stock has a market capitalization of $12.53 billion, a price-to-earnings ratio of 16.49, a price-to-earnings-growth ratio of 0.86 and a beta of 0.90. The stock’s fifty day simple moving average is $155.10 and its 200-day simple moving average is $151.71. DaVita Inc. has a 52-week low of $103.40 and a 52-week high of $169.51. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing the consensus estimate of $2.76 by ($0.17). The business had revenue of $3.26 billion during the quarter, compared to analysts’ expectations of $3.25 billion. DaVita had a net margin of 6.53% and a return on equity of 88.18%. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm earned $2.85 EPS. Equities research analysts expect that DaVita Inc. will post 9.71 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.